Imatinib targets the ATP-binding site of the BcrAbl tyrosine kinase and also inhibits the actions of other tyrosine kinases, including platelet-derived growth factor receptor-b, C-kit, and C-ABL [17]
Scientific References Jzwiak, M., Bauer, M., Kamysz, W., & Kleczkowska, P
Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine
Five clinical trials (SURPASS 1-5 trials) conducted in patients with T2DM showed that tirzepatide at 5-15 mg per week could reduce body weight (5.4-11.7kg), which was never seen with a single drug (129)
Less Progression to Stage 4 Disease in Some People Already Diagnosed With Cancer A study presented at the 2026 ASCO meeting looked at people with stage 1, 2, or 3 cancer who started either a GLP-1 drug or a DPP-4 inhibitor after diagnosis
The unrefined version (be sure to use that on your skin!) is especially high in linoleic acid that is great even for acne-prone skin